128,566 results on '"brain neoplasms"'
Search Results
52. Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer
53. Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases (CABRAMET)
54. Evaluation of the Humoral and Tumoral Molecular Alteration Profile of Brain Metastases (METALIQ)
55. Post-Operative Dosing of Dexamethasone in Patients with Brain Tumors After a Craniotomy, PODS Trial
56. Brain Tumor Intraoperative Ultrasound Database (BraTioUS-DB)
57. Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
58. Guided Meditation During Radiation Therapy for Brain Tumors (Med-RT)
59. A Study of Oral IRAK-4 Inhibitor CA-4948 in Combination With Pembrolizumab Following Stereotactic Radiosurgery in Patients With Melanoma Brain Metastases
60. The Neuro-protective Effects of Exercise in Children with Brain Tumors
61. A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
62. A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors
63. Fitness to Aid the Brain and Cognitive Skills (Fit ABCS)
64. NBM-BMX Administered Orally to Patients with Solid Tumors or Newly Diagnosed Glioblastoma
65. Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
66. Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors
67. Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
68. A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Negative Driver Genes (IVO BRAIN)
69. Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases (SUPER BRAIN)
70. Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
71. Tumor Related Epilepsy
72. Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases
73. AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases
74. Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases
75. Trial Evaluating an Enhanced Physical Activity Intervention to Improve Cognitive Late Effects in Children Treated With Cranial Radiation for Brain Tumors
76. Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
77. C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors (C-SMART)
78. Intraoperative Radiotherapy in Patients With Brain Metastases
79. 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours (5G-RUBY)
80. Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients with Active Brain Metastases (TUXEDO-5)
81. The Use of 5-ALA in Paediatric Patients with High Grade Brain Tumours (P5A)
82. Atovaquone Combined with Radiation in Children with Malignant Brain Tumors (AflacBT2303)
83. Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
84. Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)
85. 5G-EMERALD: Amivantamab in Malignant Brain Tumours (5G-EMERALD)
86. TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas (BAH2472)
87. Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
88. GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
89. Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases (PREOP-2)
90. ARRY-380 + Trastuzuamab for Breast w/ Brain Mets
91. ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids (ARISTOCRAT)
92. Stereotactic Magnetic Resonance Guided Radiation Therapy
93. Vascular Signature Mapping of Brain Tumor Genotypes (VASIM)
94. Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients with Resectable Brain Tumors
95. Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
96. Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
97. An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors
98. Seizure Control As a New Metric in Assessing Efficacy of Tumor Treatment in Patients with Low Grade Glioma
99. Chronic CED of TPT for Recurrent Malignant Glioma (TPT CED rHGG)
100. RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors (PIRATE)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.